跳至主要内容
临床试验/NCT07478549
NCT07478549尚未招募不适用

Prospective, Multicenter, Randomized Clinical Trial Evaluating the Safety of the HyperSperm Sperm Preparation Procedure.

Fecundis Lab SL2 个研究点 分布在 1 个国家目标入组 202 人开始时间: 2026年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
202
试验地点
2
主要终点
Euploidy Rate

研究概览

简要总结

Prospective, multicenter, randomized clinical study evaluating the safety of a novel sperm preparation method for in vitro fertilization (IVF), compared to standard sperm preparation procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Couples undergoing in vitro fertilization (IVF) treatment.
  • Planned use of fresh sperm samples obtained by masturbation.
  • Age between 20 and 42 years.
  • Antral follicle count ≥
  • Eligible for ovarian stimulation and embryo transfer.
  • Age between 20 and 45 years.
  • Fresh semen sample (not cryopreserved).
  • Pre-processing sperm concentration ≥ 5 × 10⁶ sperm/mL.

排除标准

  • Active sexually transmitted infection (STI).
  • Use of donor sperm.
  • Medical conditions contraindicating pregnancy or the IVF procedure.
  • Uterine anomalies associated with distortion of the uterine cavity.
  • Absence of one ovary or functional disorders preventing ovulation.
  • Diabetes mellitus or other metabolic disorders.
  • Recurrent pregnancy loss, defined as more than two clinical pregnancies without live birth.
  • - Any medical condition affecting semen quality that, in the investigator's opinion, may interfere with study participation.

研究组 & 干预措施

Standard Sperm Preparation

Active Comparator

Sperm samples in the control group will undergo traditional processing in the lab prior to insemination.

干预措施: Standard Sperm Preparation (Device)

HyperSperm

Experimental

Sperm samples in the experimental group will undergo product-specific processing in the lab prior to insemination.

干预措施: HyperSperm (Device)

结局指标

主要结局

Euploidy Rate

时间窗: From embryo biopsy and PGT analysis up to completion of genetic results, within the IVF cycle (approximately 5-7 days post-fertilization).

Proportion of embryos identified as euploid following preimplantation genetic testing (PGT) performed on embryos generated during the IVF cycle.

次要结局

  • Fertilization Rate(Approximately 16-20 hours after insemination.)
  • Cleavage Rate(Day 2-3 after fertilization.)
  • Blastocyst Formation Rate(Day 5-6 after fertilization.)
  • Embryo Quality at Cleavage Stage(Day 3 after fertilization.)
  • Embryo Quality at Blastocyst Stage(Day 5-6 after fertilization.)
  • Biochemical Pregnancy Rate(Approximately 10-14 days after embryo transfer.)
  • Clinical Pregnancy Rate(5-7 weeks of gestation following embryo transfer.)
  • Progressive Motile Sperm Count After Processing(Immediately after sperm processing on the day of oocyte retrieval.)
  • Total Sperm Motility After Processing(Immediately after sperm processing on the day of oocyte retrieval.)
  • Progressive Sperm Motility After Processing(Immediately after sperm processing on the day of oocyte retrieval.)

研究者

发起方
Fecundis Lab SL
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验